Aster DM Healthcare Affirms Its Contribution to India’s Growing Medical Value Tourism at the 7th Edition of Advantage Health Care-India 2023

Aster DM Healthcare, a key player in integrated healthcare services across the GCC and India, played a pivotal role in the recent Advantage Health Care-India summit. The 7th edition of the event, themed “ONE EARTH ONE HEALTH,” took place from August 17th to 19th, 2023, at the Mahatma Mandir Convention & Exhibition Centre in Gandhinagar, Gujarat. The summit, a joint effort by the Ministry of Health & Family Welfare (MoHFW), Government of India, and the Federation of Indian Chambers of Commerce & Industry (FICCI), coincided with the G20 4th Health Working Group & Ministers Meeting.

Dr. Azad Moopen, Founder Chairman, and Managing Director of Aster DM Healthcare, set the tone with his inaugural speech at Advantage Health Care-India 2023. He spotlighted India’s evolving healthcare image and its transition from being a cost-effective medical tourism destination to one known for exceptional quality in tertiary and quaternary care. With more than 42 JCI accredited hospitals and numerous NABH accredited ones, India is now a quality healthcare leader.

The summit brought together health ministers and officials from 70 countries, fostering partnerships in India’s burgeoning Medical Value Tourism (MVT) sector. The MVT market in India, valued at $2.89 billion in 2020, is projected to reach $13.42 billion by 2026, reflecting substantial growth potential.

Aster DM Healthcare’s role in the summit underlines its commitment to healthcare integration and excellence. Dr. Moopen emphasized India’s strengths as a medical destination offering a comprehensive range of treatments, both traditional and modern. He also revealed plans to expand services to GCC, SAARC, African, and CIS countries, showcasing Aster’s global vision.

In the fiscal year 22-23, Aster’s flagship hospitals, including Aster Medcity, Aster CMI, and Aster MIMS Calicut, served over 7600 international patients, generating significant revenue. Specialized treatments such as Oncology, Transplants, Neurosurgery, Cardiac care, and Joint replacements were highly sought after.

Dr. Azad Moopen’s active participation in sessions and roundtable discussions further solidified Aster’s position as a healthcare leader. He highlighted the role of technology, telemedicine, and innovation in building a robust MVT ecosystem in India.

Dr. Nitish Shetty, CEO of Aster DM Healthcare India, emphasized the transformative potential of India’s Medical Value Tourism sector. He underscored the convergence of quality care, affordability, and advanced technology that positions India as a global hub.

Aster DM Healthcare’s extensive presence in the Middle East contributes to its comprehensive patient services. From medical opinions to logistical support, the company’s commitment aligns with the evolving healthcare landscape.

In summary, Aster DM Healthcare’s active involvement in the Advantage Health Care-India summit reflects its dedication to shaping healthcare’s future through collaboration, innovation, and unwavering quality. The event showcased India’s ascent as a prime medical tourism destination and Aster’s pivotal role in this journey.